Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces in vivo Neuroreceptor Occupancy and Reduces Striatal Glutamate Levels

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. In-vitro Recordings of Neural Magnetic Activity From the Auditory Brainstem Using Color Centers in Diamond: A Simulation Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reduction of Pressure Pain Sensitivity as Novel Non-pharmacological Therapeutic Approach to Type 2 Diabetes: A Randomized Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance Spectroscopy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A quantitative method for the selective 5-HT2A agonist 25CN-NBOH in rat plasma and brain

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Blocking of efflux transporters in rats improves translational validation of brain radioligands

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Characterization of the serotonin 2A receptor selective PET tracer (R)-[F-18]MH.MZ in the human brain

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Chemogenetic studies with the ligand clozapine N-oxide (CNO) are predicated upon the assumption that CNO is devoid of actions at natural neuroreceptors. However, recent evidence shows that CNO may be converted back to clozapine (CLZ) in vivo, which could yield plasma concentrations that may be sufficient to occupy inter alia dopamine D2/3 and serotonin 5HT2A receptors in living brain. To test this phenomenon, we measured striatal dopamine D2/3 receptor occupancy with [18F]fallypride PET and serotonin 5HT2A occupancy ex vivo using [18F]MH.MZ. We found a CNO dose-dependent effect on the availability of both neuroreceptor sites. In parallel MR spectroscopy experiments, we found that CNO reduced creatine + phosphcreatine (Cr+PCr) and increased N-acetylaspartate + N-acetylaspartylglutamate (NAA+NAAG) signals in the prefrontal cortex, and also reduced the glutamate signal in dorsal striatum, with peak effect at 2 mg/kg. Thus, our findings suggest that conversion of CNO to CLZ in living rats imparts significant occupancy at endogenous neuroreceptors and significant changes to neurometabolite levels.

OriginalsprogEngelsk
TidsskriftFrontiers in Neuroscience
Vol/bind13
Sider (fra-til)187
ISSN1662-4548
DOI
StatusUdgivet - 2019

ID: 59056092